APDN to Report FQ2’23 Financial Results; Investor Conference Call/Webcast 5/11
May 3rd, 2023
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
CertainT® Featured in NY Times Re: Need for Transparency and Compliance
April 7th, 2023
APDN Milestone: Largest Single Large-Scale linearDNA™ Shipment to Date
March 29th, 2023
In Brief This Week: Quest Diagnostics, Applied DNA, Enzo Biochem, More
March 27th, 2023
APDN Submits Validation Package to NYS DOH for Approval of PGx Assay
March 22nd, 2023
Applied DNA Reports First Quarter Fiscal 2023 Financial Results
February 9th, 2023
APDN to Report Q1 FY’23 Financial Results; Investor Conference Call/Webcast 2/9
February 2nd, 2023
Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
January 5th, 2023
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
December 14th, 2022